Results 171 to 180 of about 1,828,960 (298)
This study explores firm growth and its relation with firm-specific capabilities. Organisations can benefit from growth in many ways, including greater efficiencies through economies of scale, increased power, the ability to withstand environmental ...
Ron Kemp, R.L.C. Philipsen
core
Mutant p53R273H disrupts PDPK1 homodimerization and contributes to PDPK1 activation
How mutant p53R273H drives AKT signaling is unclear. We show that p53R273H, but not wild‐type, directly binds PDPK1 via a mutation‐dependent conformational change. This interaction disrupts inhibitory PDPK1 homodimerization and enhances AKT phosphorylation.
Mei Chee Lim +11 more
wiley +1 more source
Digital Transformational Leadership and Coordinated Care in European Primary Healthcare: The Mediating Role of Patient Agility. [PDF]
Hawrysz L +2 more
europepmc +1 more source
Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba +5 more
wiley +1 more source
Addressing Reproducibility Challenges in High-Throughput Photochemistry
Brenda Pijper +9 more
doaj +1 more source
The interplay of influencing factors in physical activity promotion for older men: insights through the capability approach. [PDF]
Schuck T, Loss J, Tittlbach S.
europepmc +1 more source
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David +12 more
wiley +1 more source
Influence of Dynamic Capabilities in Creating Disruptive Innovation
The aim of this paper is to demonstrate the influence of Dynamic Capabilities in creating Disruptive Innovation. For doing so the concepts of Dynamic Capabilities and Disruptive Innovation are reviewed.
Čiutienė, Rūta +1 more
core +1 more source
Industry-defined opportunities for advancing big data capabilities in biopharmaceutical manufacturing. [PDF]
Hart R +4 more
europepmc +1 more source
Reprogramming tumor cells with LCOR mRNA nanotherapy to enhance immunotherapy
LCOR (Ligand‐dependent corepressor) mRNA encapsulated in polymeric nanoparticles restores LCOR activity in tumor cells, constraining aggressive tumor cell states and increasing tumor immunogenicity. This reprogramming makes tumor cells more vulnerable to T‐cell attack and enhances their response to immune‐checkpoint immunotherapy.
Gabriel Serra‐Mir +9 more
wiley +1 more source

